When it comes to life-threatening diseases, we are one family. We at Kiadis are focusing our research & development on NK cell therapeutics, leveraging the natural strengths of our immune systems to source the best cells for life.
View Top Employees from Kiadis PharmaWebsite | http://www.kiadis.com |
Ticker | AMS:KDS |
Revenue | $57.4 million |
Funding | $65.7 million |
Employees | 61 (61 on RocketReach) |
Founded | 1997 |
Address | Paasheuvelweg 25A, Amsterdam, North Holland 1105BP, NL |
Phone | +31 20 240 5250 |
Fax | +31 20 240 5251 |
Technologies |
JavaScript,
HTML,
PHP
+39 more
(view full list)
|
Industry | Biotechnology, Manufacturing General, Biopharma, Cell therapies for blood cancer patients, Manufacturing, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 2 Million |
Keywords | Kiadis Pharma, Atir101, Pharmaceutical Companies, Topman Arthur Lahr, Regulatory Placement |
SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 541711 Companies, NAICS Code 325 Companies, NAICS Code 5417 Companies |
Looking for a particular Kiadis Pharma employee's phone or email?
The Kiadis Pharma annual revenue was $57.4 million in 2024.
Robert Igarashi is the Vice President of Discovery and Pre-Clinical Development of Kiadis Pharma.
61 people are employed at Kiadis Pharma.
Kiadis Pharma is based in Amsterdam, North Holland.
The NAICS codes for Kiadis Pharma are [54, 54171, 541, 32, 541711, 325, 5417].
The SIC codes for Kiadis Pharma are [2834, 28, 283].